Updated on 2025/06/02

All information, except for affiliations, is reprinted from the information registered on researchmap.

写真a

 
Kenichi Asano
 
Organization
Graduate School of Medicine Department of Medicine Microbiology Professor
School of Medicine Medical Course
Title
Professor
External link

Degree

  • 博士(医学) ( 東京医科歯科大学大学院 )

Research Interests

  • Nephrology

  • ワクチン

  • Immunology

  • 感染防御

  • 組織修復

  • Macrophage

  • 自然免疫

Research Areas

  • Life Science / Pathological biochemistry

  • Life Science / Immunology

Education

  • Tokyo Medical and Dental University Graduate School of Medicine

    2002.4 - 2006.3

      More details

  • Tokyo Medical and Dental University   Faculty of Medicine

    - 1999

      More details

Research History

  • Yokohama City University School of Medicine   Department of Microbiology and Molecular Biodefence Research   Professor

    2024.4

      More details

    Country:Japan

    researchmap

  • Tokyo University of Pharmacy and Life Science   Associate Professor

    2011.4 - 2024.3

      More details

  • RIKEN

    2008.4 - 2011.3

      More details

  • Brigham and Women's Hospital and Harvard Medical School

    2006.4 - 2008.3

      More details

  • 文部科学省   研究振興局   学術調査官

    2019.8 - 2021.7

      More details

  • 科学技術振興機構   さきがけ研究員

    2011.10 - 2015.3

      More details

▼display all

Professional Memberships

▼display all

Papers

  • Egr2 drives the differentiation of Ly6Chi monocytes into fibrosis-promoting macrophages in metabolic dysfunction-associated steatohepatitis in mice. International journal

    Ayaka Iwata, Juri Maruyama, Shibata Natsuki, Akira Nishiyama, Tomohiko Tamura, Minoru Tanaka, Shigeyuki Shichino, Takao Seki, Toshihiko Komai, Tomohisa Okamura, Keishi Fujio, Masato Tanaka, Kenichi Asano

    Communications biology   7 ( 1 )   681 - 681   2024.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Metabolic dysfunction-associated steatohepatitis (MASH), previously called non-alcoholic steatohepatitis (NASH), is a growing concern worldwide, with liver fibrosis being a critical determinant of its prognosis. Monocyte-derived macrophages have been implicated in MASH-associated liver fibrosis, yet their precise roles and the underlying differentiation mechanisms remain elusive. In this study, we unveil a key orchestrator of this process: long chain saturated fatty acid-Egr2 pathway. Our findings identify the transcription factor Egr2 as the driving force behind monocyte differentiation into hepatic lipid-associated macrophages (hLAMs) within MASH liver. Notably, Egr2-deficiency reroutes monocyte differentiation towards a macrophage subset resembling resident Kupffer cells, hampering hLAM formation. This shift has a profound impact, suppressing the transition from benign steatosis to liver fibrosis, demonstrating the critical pro-fibrotic role played by hLAMs in MASH pathogenesis. Long-chain saturated fatty acids that accumulate in MASH liver emerge as potent inducers of Egr2 expression in macrophages, a process counteracted by unsaturated fatty acids. Furthermore, oral oleic acid administration effectively reduces hLAMs in MASH mice. In conclusion, our work not only elucidates the intricate interplay between saturated fatty acids, Egr2, and monocyte-derived macrophages but also highlights the therapeutic promise of targeting the saturated fatty acid-Egr2 axis in monocytes for MASH management.

    DOI: 10.1038/s42003-024-06357-5

    PubMed

    researchmap

  • The early neutrophil-committed progenitors aberrantly differentiate into immunoregulatory monocytes during emergency myelopoiesis Reviewed

    Naoki Ikeda, Hiroaki Kubota, Risa Suzuki, Mitsuki Morita, Ayana Yoshimura, Yuya Osada, Keigo Kishida, Daiki Kitamura, Ayaka Iwata, Satoshi Yotsumoto, Daisuke Kurotaki, Koutarou Nishimura, Akira Nishiyama, Tomohiko Tamura, Takashi Kamatani, Tatsuhiko Tsunoda, Miyako Murakawa, Yasuhiro Asahina, Yoshihiro Hayashi, Hironori Harada, Yuka Harada, Asumi Yokota, Hideyo Hirai, Takao Seki, Makoto Kuwahara, Masakatsu Yamashita, Shigeyuki Shichino, Masato Tanaka, Kenichi Asano

    Cell Reports   42 ( 3 )   112165 - 112165   2023.3

     More details

    Authorship:Corresponding author   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.celrep.2023.112165

    researchmap

  • CD169+ macrophages in lymph node and spleen critically depend on dual RANK and LTbetaR signaling. Reviewed International journal

    Abdouramane Camara, Alice C Lavanant, Jun Abe, Henri Lee Desforges, Yannick O Alexandre, Erika Girardi, Zinaida Igamberdieva, Kenichi Asano, Masato Tanaka, Thomas Hehlgans, Klaus Pfeffer, Sébastien Pfeffer, Scott N Mueller, Jens V Stein, Christopher G Mueller

    Proceedings of the National Academy of Sciences of the United States of America   119 ( 3 )   2022.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    CD169+ macrophages reside in lymph node (LN) and spleen and play an important role in the immune defense against pathogens. As resident macrophages, they are responsive to environmental cues to shape their tissue-specific identity. We have previously shown that LN CD169+ macrophages require RANKL for formation of their niche and their differentiation. Here, we demonstrate that they are also dependent on direct lymphotoxin beta (LTβ) receptor (R) signaling. In the absence or the reduced expression of either RANK or LTβR, their differentiation is perturbed, generating myeloid cells expressing SIGN-R1 in LNs. Conditions of combined haploinsufficiencies of RANK and LTβR revealed that both receptors contribute equally to LN CD169+ macrophage differentiation. In the spleen, the Cd169-directed ablation of either receptor results in a selective loss of marginal metallophilic macrophages (MMMs). Using a RANKL reporter mouse, we identify splenic marginal zone stromal cells as a source of RANKL and demonstrate that it participates in MMM differentiation. The loss of MMMs had no effect on the splenic B cell compartments but compromised viral capture and the expansion of virus-specific CD8+ T cells. Taken together, the data provide evidence that CD169+ macrophage differentiation in LN and spleen requires dual signals from LTβR and RANK with implications for the immune response.

    DOI: 10.1073/pnas.2108540119

    PubMed

    researchmap

  • Replication of Influenza A Virus in Secondary Lymphatic Tissue Contributes to Innate Immune Activation. Reviewed International journal

    Sarah-Kim Friedrich, Rosa Schmitz, Michael Bergerhausen, Judith Lang, Vikas Duhan, Cornelia Hardt, Matthias Tenbusch, Marco Prinz, Kenichi Asano, Hilal Bhat, Thamer A Hamdan, Philipp Alexander Lang, Karl Sebastian Lang

    Pathogens (Basel, Switzerland)   10 ( 5 )   2021.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The replication of viruses in secondary lymphoid organs guarantees sufficient amounts of pattern-recognition receptor ligands and antigens to activate the innate and adaptive immune system. Viruses with broad cell tropism usually replicate in lymphoid organs; however, whether a virus with a narrow tropism relies on replication in the secondary lymphoid organs to activate the immune system remains not well studied. In this study, we used the artificial intravenous route of infection to determine whether Influenza A virus (IAV) replication can occur in secondary lymphatic organs (SLO) and whether such replication correlates with innate immune activation. Indeed, we found that IAV replicates in secondary lymphatic tissue. IAV replication was dependent on the expression of Sialic acid residues in antigen-presenting cells and on the expression of the interferon-inhibitor UBP43 (Usp18). The replication of IAV correlated with innate immune activation, resulting in IAV eradication. The genetic deletion of Usp18 curbed IAV replication and limited innate immune activation. In conclusion, we found that IAV replicates in SLO, a mechanism which allows innate immune activation.

    DOI: 10.3390/pathogens10050622

    PubMed

    researchmap

  • Liposome induction of CD8+ T cell responses depends on CD169+ macrophages and Batf3-dependent dendritic cells and is enhanced by GM3 inclusion. Reviewed International journal

    J Grabowska, A J Affandi, D van Dinther, M K Nijen Twilhaar, K Olesek, L Hoogterp, M Ambrosini, D A M Heijnen, L Klaase, A Hidalgo, K Asano, P R Crocker, G Storm, Y van Kooyk, J M M den Haan

    Journal of controlled release : official journal of the Controlled Release Society   331   309 - 320   2021.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Cancer vaccines aim to efficiently prime cytotoxic CD8+ T cell responses which can be achieved by vaccine targeting to dendritic cells. CD169+ macrophages have been shown to transfer antigen to dendritic cells and could act as an alternative target for cancer vaccines. Here, we evaluated liposomes containing the CD169/Siglec-1 binding ligand, ganglioside GM3, and the non-binding ligand, ganglioside GM1, for their capacity to target antigens to CD169+ macrophages and to induce immune responses. CD169+ macrophages demonstrated specific uptake of GM3 liposomes in vitro and in vivo that was dependent on a functional CD169 receptor. Robust antigen-specific CD8+ and CD4+ T and B cell responses were observed upon intravenous administration of GM3 liposomes containing the model antigen ovalbumin in the presence of adjuvant. Immunization of B16-OVA tumor bearing mice with all liposomes resulted in delayed tumor growth and improved survival. The absence of CD169+ macrophages, functional CD169 molecules, and cross-presenting Batf3-dependent dendritic cells (cDC1s) significantly impaired CD8+ T cell responses, while B cell responses were less affected. In conclusion, we demonstrate that inclusion of GM3 in liposomes enhance immune responses and that splenic CD169+ macrophages and cDC1s are required for induction of CD8+ T cell immunity after liposomal vaccination.

    DOI: 10.1016/j.jconrel.2021.01.029

    PubMed

    researchmap

  • Frontline Science: Conversion of neutrophils into atypical Ly6G+ SiglecF+ immune cells with neurosupportive potential in olfactory neuroepithelium. Reviewed International journal

    Kei Ogawa, Kenichi Asano, Satoshi Yotsumoto, Tsuyoshi Yamane, Makoto Arita, Yoshihiro Hayashi, Hironori Harada, Chieko Makino-Okamura, Hidehiro Fukuyama, Kenji Kondo, Tatsuya Yamasoba, Masato Tanaka

    Journal of leukocyte biology   109 ( 3 )   481 - 496   2021.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Neutrophils are generally considered as short-lived, homogenous, and terminally differentiated phagocytes that play crucial roles in conquering infection, although they occasionally cause severe collateral tissue damage or chronic inflammation. Recent reports have indicated that neutrophils also play a protective role in inflammation resolution and tissue repair. However, how terminally differentiated neutrophils have diverse functions remains unclear. Here, we show that neutrophils undergo conversion into Ly6G+ SiglecF+ double-positive cells expressing neurosupportive genes in the olfactory neuroepithelium (OE) under an inflammatory state. Through comprehensive flow cytometric analysis of murine nose, we identified Ly6G+ SiglecF+ double-positive cells that reside only in the OE under steady-state conditions. Double-positive cells were neutrophil-derived cells and increased by more than 10-fold during inflammation or tissue injury. We found that neutrophils infiltrate into the nose to express proinflammatory genes in the acute phase of inflammatory state, and they gradually change their surface markers and gene expression, expressing some neurogenesis-related genes in addition to inflammation related genes in the later phase. As the OE is known to have exceptionally high regeneration capacity as a nervous system, these findings suggest that neutrophils have the potential to contribute neurogenesis after conversion in peripheral nervous tissues, providing a challenge on a classic view of neutrophils as terminally differentiated leukocytes.

    DOI: 10.1002/JLB.1HI0620-190RR

    PubMed

    researchmap

  • Immunoregulatory Monocyte Subset Promotes Metastasis Associated With Therapeutic Intervention for Primary Tumor. Reviewed International journal

    Takumi Shibuya, Asami Kamiyama, Hirotaka Sawada, Kenta Kikuchi, Mayu Maruyama, Rie Sawado, Naoki Ikeda, Kenichi Asano, Daisuke Kurotaki, Tomohiko Tamura, Atsuko Yoneda, Keisuke Imada, Takashi Satoh, Shizuo Akira, Masato Tanaka, Satoshi Yotsumoto

    Frontiers in immunology   12   663115 - 663115   2021

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Systemic and local inflammation associated with therapeutic intervention of primary tumor occasionally promotes metastatic recurrence in mouse and human. However, it remains unclear what types of immune cells are involved in this process. Here, we found that the tissue-repair-promoting Ym1+Ly6Chi monocyte subset expanded as a result of systemic and local inflammation induced by intravenous injection of lipopolysaccharide or resection of primary tumor and promoted lung metastasis originating from circulating tumor cells (CTCs). Deletion of this subset suppressed metastasis induced by the inflammation. Furthermore, transfer of Ym1+Ly6Chi monocytes into naïve mice promoted lung metastasis in the mice. Ym1+Ly6Chi monocytes highly expressed matrix metalloproteinase-9 (MMP-9) and CXCR4. MMP-9 inhibitor and CXCR4 antagonist decreased Ym1+Ly6Chi-monocyte-promoted lung metastasis. These findings indicate that Ym1+Ly6Chi monocytes are therapeutic target cells for metastasis originating from CTCs associated with systemic and local inflammation. In addition, these findings provide a novel predictive cellular biomarker for metastatic recurrence after intervention for primary tumor.

    DOI: 10.3389/fimmu.2021.663115

    PubMed

    researchmap

  • Early Fate Defines Microglia and Non-parenchymal Brain Macrophage Development. Reviewed International journal

    Sebastian G Utz, Peter See, Wiebke Mildenberger, Morgane Sonia Thion, Aymeric Silvin, Mirjam Lutz, Florian Ingelfinger, Nirmala Arul Rayan, Iva Lelios, Anne Buttgereit, Kenichi Asano, Shyam Prabhakar, Sonia Garel, Burkhard Becher, Florent Ginhoux, Melanie Greter

    Cell   181 ( 3 )   557 - 573   2020.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Central nervous system (CNS) macrophages comprise microglia and border-associated macrophages (BAMs) residing in the meninges, the choroid plexus, and the perivascular spaces. Most CNS macrophages emerge during development, with the exception of choroid plexus and dural macrophages, which are replaced by monocytes in adulthood. Whether microglia and BAMs share a developmental program or arise from separate lineages remains unknown. Here, we identified two phenotypically, transcriptionally, and locally distinct brain macrophages throughout development, giving rise to either microglia or BAMs. Two macrophage populations were already present in the yolk sac suggesting an early segregation. Fate-mapping models revealed that BAMs mostly derived from early erythro-myeloid progenitors in the yolk sac. The development of microglia was dependent on TGF-β, whereas the genesis of BAMs occurred independently of this cytokine. Collectively, our data show that developing parenchymal and non-parenchymal brain macrophages are separate entities in terms of ontogeny, gene signature, and requirement for TGF-β.

    DOI: 10.1016/j.cell.2020.03.021

    PubMed

    researchmap

  • Usp18 Expression in CD169+ Macrophages is Important for Strong Immune Response after Vaccination with VSV-EBOV. Reviewed International journal

    Sarah-Kim Friedrich, Rosa Schmitz, Michael Bergerhausen, Judith Lang, Lamin B Cham, Vikas Duhan, Dieter Häussinger, Cornelia Hardt, Marylyn Addo, Marco Prinz, Kenichi Asano, Philipp Alexander Lang, Karl Sebastian Lang

    Vaccines   8 ( 1 )   2020.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Ebola virus epidemics can be effectively limited by the VSV-EBOV vaccine (Ervebo) due to its rapid protection abilities; however, side effects prevent the broad use of VSV-EBOV as vaccine. Mechanisms explaining the efficient immune activation after single injection with the VSV-EBOV vaccine remain mainly unknown. Here, using the clinically available VSV-EBOV vaccine (Ervebo), we show that the cell-intrinsic expression of the interferon-inhibitor Usp18 in CD169+ macrophages is one important factor modulating the anti-Ebola virus immune response. The absence of Usp18 in CD169+ macrophages led to the reduced local replication of VSV-EBOV followed by a diminished innate as well as adaptive immune response. In line, CD169-Cre+/ki x Usp18fl/fl mice showed reduced innate and adaptive immune responses against the VSV wildtype strain and died quickly after infection, suggesting that a lack of Usp18 makes mice more susceptible to the side effects of the VSV vector. In conclusion, our study shows that Usp18 expression in CD169+ macrophages is one important surrogate marker for effective vaccination against VSV-EBOV, and probably other VSV-based vaccines also.

    DOI: 10.3390/vaccines8010142

    PubMed

    researchmap

  • Emergence of immunoregulatory Ym1+Ly6Chi monocytes during recovery phase of tissue injury. Reviewed International journal

    Naoki Ikeda, Kenichi Asano, Kenta Kikuchi, Yoshimi Uchida, Hiroki Ikegami, Ryo Takagi, Satoshi Yotsumoto, Takumi Shibuya, Chieko Makino-Okamura, Hidehiro Fukuyama, Takashi Watanabe, Masaki Ohmuraya, Kimi Araki, Gen Nishitai, Masato Tanaka

    Science immunology   3 ( 28 )   2018.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Ly6Chi monocytes migrate to injured sites and induce inflammation in the acute phase of tissue injury. However, once the causes of tissue injury are eliminated, monocyte-derived macrophages contribute to the resolution of inflammation and tissue repair. It remains unclear whether the emergence of these immunoregulatory macrophages is attributed to the phenotypic conversion of inflammatory monocytes in situ or to the recruitment of bone marrow-derived regulatory cells de novo. Here, we identified a subpopulation of Ly6Chi monocytes that contribute to the resolution of inflammation and tissue repair. Ym1+Ly6Chi monocytes greatly expanded in bone marrow during the recovery phase of systemic inflammation or tissue injury. Ym1+Ly6Chi monocytes infiltrating into an injured site exhibited immunoregulatory and tissue-reparative phenotypes. Deletion of Ym1+Ly6Chi monocytes resulted in delayed recovery from colitis. These results demonstrate that a distinct monocyte subpopulation destined to act in immunoregulation is generated in bone marrow and participates in resolution of inflammation and tissue repair.

    DOI: 10.1126/sciimmunol.aat0207

    PubMed

    researchmap

  • Macrophages Switch Their Phenotype by Regulating Maf Expression during Different Phases of Inflammation. Reviewed International journal

    Kenta Kikuchi, Mayumi Iida, Naoki Ikeda, Shigetaka Moriyama, Michito Hamada, Satoru Takahashi, Hiroshi Kitamura, Takashi Watanabe, Yoshinori Hasegawa, Koji Hase, Takeshi Fukuhara, Hideyo Sato, Eri H Kobayashi, Takafumi Suzuki, Masayuki Yamamoto, Masato Tanaka, Kenichi Asano

    Journal of immunology (Baltimore, Md. : 1950)   201 ( 2 )   635 - 651   2018.7

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Macrophages manifest distinct phenotype according to the organs in which they reside. In addition, they flexibly switch their character in adaptation to the changing environment. However, the molecular basis that explains the conversion of the macrophage phenotype has so far been unexplored. We find that CD169+ macrophages change their phenotype by regulating the level of a transcription factor Maf both in vitro and in vivo in C57BL/6J mice. When CD169+ macrophages were exposed to bacterial components, they expressed an array of acute inflammatory response genes in Maf-dependent manner and simultaneously start to downregulate Maf. This Maf suppression is dependent on accelerated degradation through proteasome pathway and microRNA-mediated silencing. The downregulation of Maf unlocks the NF-E2-related factor 2-dominant, cytoprotective/antioxidative program in the same macrophages. The present study provides new insights into the previously unanswered question of how macrophages initiate proinflammatory responses while retaining their capacity to repair injured tissues during inflammation.

    DOI: 10.4049/jimmunol.1800040

    PubMed

    researchmap

  • Intestinal CD169(+) macrophages initiate mucosal inflammation by secreting CCL8 that recruits inflammatory monocytes. Reviewed International journal

    Kenichi Asano, Naomichi Takahashi, Mikiko Ushiki, Misa Monya, Fumiaki Aihara, Erika Kuboki, Shigetaka Moriyama, Mayumi Iida, Hiroshi Kitamura, Chun-Hong Qiu, Takashi Watanabe, Masato Tanaka

    Nature communications   6   7802 - 7802   2015.7

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Lamina propria (LP) macrophages are constantly exposed to commensal bacteria, and are refractory to those antigens in an interleukin (IL)-10-dependent fashion. However, the mechanisms that discriminate hazardous invasion by bacteria from peaceful co-existence with them remain elusive. Here we show that CD169(+) macrophages reside not at the villus tip, but at the bottom-end of the LP microenvironment. Following mucosal injury, the CD169(+) macrophages recruit inflammatory monocytes by secreting CCL8. Selective depletion of CD169(+) macrophages or administration of neutralizing anti-CCL8 antibody ameliorates the symptoms of experimentally induced colitis in mice. Collectively, we identify an LP-resident macrophage subset that links mucosal damage and inflammatory monocyte recruitment. Our results suggest that CD169(+) macrophage-derived CCL8 serves as an emergency alert for the collapse of barrier defence, and is a promising target for the suppression of mucosal injury.

    DOI: 10.1038/ncomms8802

    PubMed

    researchmap

  • Identification of Pathogenic Cardiac CD11c+ Macrophages in Nod1-Mediated Acute Coronary Arteritis. Reviewed International journal

    Yoshitomo Motomura, Shunsuke Kanno, Kenichi Asano, Masato Tanaka, Yutaka Hasegawa, Hideki Katagiri, Takashi Saito, Hiromitsu Hara, Hisanori Nishio, Toshiro Hara, Sho Yamasaki

    Arteriosclerosis, thrombosis, and vascular biology   35 ( 6 )   1423 - 33   2015.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: Nod1 is an intracellular pattern recognition receptor for bacterial peptidoglycan fragments. We previously reported that a synthetic Nod1 ligand, FK565, induced acute coronary arteritis in mice similar to that of Kawasaki disease. However, the molecular mechanisms underlying this characteristic inflammation have remained elusive. APPROACH AND RESULTS: We found that CD11c(+)MHC class II(+) cells accumulated in the heart of FK565-treated mice before arteritis development. Morphological features and gene expression signatures of the cardiac CD11c(+)MHC class II(+) cells suggested that this population is closely related to macrophages, and thus, we designated them cardiac CD11c(+) macrophages. Nod1 in nonhematopoietic cells, rather than hematopoietic cells, was required for the increase of cardiac CD11c(+) macrophages and arteritis development. Among nonhematopoietic cells, cardiac endothelial cells produced a large amount of chemokines in response to FK565. Endothelial cell-specific blockade of Nod1 signaling suppressed FK565-induced expression of these chemokines, accumulation of cardiac CD11c(+) macrophages, and subsequent coronary arteritis development. We also found that CCR2(+)Ly6C(hi) inflammatory monocytes in peripheral blood supplied precursors of cardiac CD11c(+) macrophages. CCR2-deficient mice or pertussis toxin-treated mice exhibited decreased numbers of cardiac CD11c(+) macrophages and reduced arteritis. CONCLUSIONS: These results suggest that Ly6C(hi) monocytes are recruited to FK565-activated endothelial cells to generate cardiac CD11c(+) macrophages, which play a pivotal role in the pathogenesis of acute coronary arteritis.

    DOI: 10.1161/ATVBAHA.114.304846

    PubMed

    researchmap

  • Vascular-resident CD169-positive monocytes and macrophages control neutrophil accumulation in the kidney with ischemia-reperfusion injury. Reviewed International journal

    Kazunori Karasawa, Kenichi Asano, Shigetaka Moriyama, Mikiko Ushiki, Misa Monya, Mayumi Iida, Erika Kuboki, Hideo Yagita, Keiko Uchida, Kosaku Nitta, Masato Tanaka

    Journal of the American Society of Nephrology : JASN   26 ( 4 )   896 - 906   2015.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Monocytes and kidney-resident macrophages are considered to be involved in the pathogenesis of renal ischemia-reperfusion injury (IRI). Several subsets of monocytes and macrophages are localized in the injured tissue, but the pathologic roles of these cells are not fully understood. Here, we show that CD169(+) monocytes and macrophages have a critical role in preventing excessive inflammation in IRI by downregulating intercellular adhesion molecule-1 (ICAM-1) expression on vascular endothelial cells. Mice depleted of CD169(+) cells showed enhanced endothelial ICAM-1 expression and developed irreversible renal damage associated with infiltration of a large number of neutrophils. The perivascular localization of CD169(+) monocytes and macrophages indicated direct interaction with blood vessels, and coculture experiments showed that the direct interaction of CD169(+) cell-depleted peripheral blood leukocytes augments the expression levels of ICAM-1 on endothelial cells. Notably, the transfer of Ly6C(lo) monocytes into CD169(+) cell-depleted mice rescued the mice from lethal renal injury and normalized renal ICAM-1 expression levels, indicating that the Ly6C(lo) subset of CD169(+) monocytes has a major role in the regulation of inflammation. Our findings highlight the previously unknown role of CD169(+) monocytes and macrophages in the maintenance of vascular homeostasis and provide new approaches to the treatment of renal IRI.

    DOI: 10.1681/ASN.2014020195

    PubMed

    researchmap

  • CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. Reviewed International journal

    Kenichi Asano, Ami Nabeyama, Yasunobu Miyake, Chun-Hong Qiu, Ai Kurita, Michio Tomura, Osami Kanagawa, Shin-ichiro Fujii, Masato Tanaka

    Immunity   34 ( 1 )   85 - 95   2011.1

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    The generation of tumor-directed cytotoxic T lymphocytes is considered crucial for the induction of antitumor immunity. To activate these CD8(+) T cells, antigen-presenting cells (APCs) must initially acquire tumor cell-associated antigens. The major source of tumor antigens is dead tumor cells, but little is known about how APCs in draining lymph nodes acquire and crosspresent these antigens. Here we show that CD169(+) macrophages phagocytose dead tumor cells transported via lymphatic flow and subsequently crosspresent tumor antigens to CD8(+) T cells. Subcutaneous immunization with irradiated tumor cells protects mice from syngenic tumor. However, tumor antigen-specific CD8(+) T cell activation and subsequent antitumor immunity are severely impaired in mice depleted with CD169(+) macrophages. Neither migratory dendritic cells (DCs) nor lymph node-resident conventional DCs are essential for the crosspresentation of tumor antigens. Thus, we have identified CD169(+) macrophages as lymph node-resident APCs dominating early activation of tumor antigen-specific CD8(+) T cells.

    DOI: 10.1016/j.immuni.2010.12.011

    PubMed

    researchmap

  • Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases. Reviewed International journal

    Naotake Tsuboi, Kenichi Asano, Michael Lauterbach, Tanya N Mayadas

    Immunity   28 ( 6 )   833 - 46   2008.6

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    Inflammation mediated by antibody-antigen complexes contributes to autoimmune diseases. Mice deficient in the common Fcgamma-chain are protected from IgG-mediated glomerulonephritis and the reverse passive Arthus (RPA) reaction and FcR-bearing macrophages, and mast cells have been assigned primary roles in these processes. Here we demonstrate that neutrophil-selective transgenic expression of the two uniquely human neutrophil Fc gamma receptors (FcgammaRs), FcgammaRIIA and FcgammaRIIIB, in Fcgamma-chain-deficient mice restored susceptibility to progressive glomerulonephritis and the cutaneous RPA reaction. FcgammaRIIIB and FcgammaRIIA mediated neutrophil accumulation, whereas FcgammaRIIA alone promoted organ injury. In a model of soluble immune complexes deposited within the vasculature, FcgammaRIIIB was responsible for neutrophil slow rolling and adhesion whereas in the cremaster RPA, induced by both vascular and tissue soluble immune complexes, FcgammaRIIA predominated. Thus, human FcgammaRs on neutrophils serve as molecular links between antibody and immunological disease, with FcgammaRIIA promoting tissue injury and FcgammaRIIIB and FcgammaRIIA displaying specialized context-dependent functions in neutrophil recruitment.

    DOI: 10.1016/j.immuni.2008.04.013

    PubMed

    researchmap

  • Maintenance of self-tolerance by apoptotic cell clearance. Reviewed International journal

    Masato Tanaka, Yasunobu Miyake, Kenichi Asano

    Frontiers in bioscience : a journal and virtual library   13   6043 - 9   2008.5

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)  

    Innate immune cells are genetically conferred the ability to recognize microorganisms as "non-self", and to induce appropriate immune responses to eliminate them. On the other hand, immune cells should recognize self cells in order to avoid attacking normal tissues. For this purpose, immune cells make use of self-cell corpses. When cells undergo apoptosis, cell corpses are rapidly phagocytosed by phagocytes, such as macrophages and dendritic cells. These phagocytes present self antigens derived from dead cell corpses to induce tolerance. Impairment of apoptotic cell clearance often results in autoimmune disorder. Intravenous injection of dead cell corpses can induce tolerance to cell-associated antigens, and this strategy has potential use in the treatment of various autoimmune and inflammatory disorders in human. Injected dead cell corpses are rapidly cleared by phagocytes located in the marginal zone (MZ) of spleen. Among those phagocytes, macrophages play a critical role in the rapid clearance of dead cell corpses, and the subsequent induction of tolerance to cell-associated antigens.

    PubMed

    researchmap

  • Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens. Reviewed International journal

    Yasunobu Miyake, Kenichi Asano, Hitomi Kaise, Miho Uemura, Manabu Nakayama, Masato Tanaka

    The Journal of clinical investigation   117 ( 8 )   2268 - 78   2007.8

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    Injection of apoptotic cells can induce suppression of immune responses to cell-associated antigens. Here, we show that intravenous injection of apoptotic cells expressing a fragment of myelin oligodendrocyte glycoprotein (MOG) reduced MOG-specific T cell response and prevented the development of EAE. Since injected apoptotic cells accumulated initially in the splenic marginal zone (MZ), the role of macrophages in the MZ in immune suppression was examined using transgenic mice in which these cells could be transiently deleted by diphtheria toxin (DT) injection. DT-treated mice became susceptible to EAE even though MOG-expressing apoptotic cells were preinjected. Deletion of the macrophages caused delayed clearance of injected dying cells in the MZ. In wild-type mice, injected apoptotic cells were selectively engulfed by CD8 alpha(+) DCs, which are responsible for suppression of immune responses to cell-associated antigens. In contrast, deletion of macrophages in the MZ caused aberrant phagocytosis of injected dying cells by CD8 alpha(-)CD11b(+) DCs. These results indicate that macrophages in the MZ regulate not only efficient clearance of apoptotic cells but also selective engulfment of dying cells by CD8 alpha(+) DCs and that functional failure of these unique macrophages impairs suppression of immune responses to cell-associated antigens.

    PubMed

    researchmap

  • Masking of phosphatidylserine inhibits apoptotic cell engulfment and induces autoantibody production in mice. International journal

    Kenichi Asano, Miyu Miwa, Keiko Miwa, Rikinari Hanayama, Hiroko Nagase, Shigekazu Nagata, Masato Tanaka

    The Journal of experimental medicine   200 ( 4 )   459 - 67   2004.8

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    Apoptotic cells are rapidly phagocytosed by professional phagocytes, such as macrophages and dendritic cells. This process prevents the release of potentially noxious or immunogenic intracellular materials from dying cells, and is thought to play a critical role for the maintenance of normal functions in surrounding tissues. Milk fat globule-EGF-factor 8 (MFG-E8), secreted by activated macrophages and immature dendritic cells, links apoptotic cells and phagocytes, and promotes phagocytosis of apoptotic cells. Here, we report that an MFG-E8 mutant, designated as D89E, carrying a point mutation in an RGD motif, inhibited not only the phagocytosis of apoptotic cells by a wide variety of phagocytes, but also inhibited the enhanced production of IL-10 by thioglycollate-elicited peritoneal macrophages phagocytosing apoptotic cells. When intravenously injected into mice, the D89E protein induced the production of autoantibodies including antiphospholipids antibodies and antinuclear antibodies. The production of autoantibodies was enhanced by the coinjection of syngeneic apoptotic thymocytes. After the induction of autoantibody production by D89E, the treated mice showed a long-term elevation of the titer for autoantibodies, and developed IgG deposition in the glomeruli. These results indicated that the impairment of apoptotic cell phagocytosis led to autoantibody production.

    PubMed

    researchmap

  • Aberrant monocytopoiesis drives granuloma development in sarcoidosis. Reviewed International journal

    Ryosuke Hiranuma, Ryota Sato, Kiyoshi Yamaguchi, Satoshi Nakamizo, Kenichi Asano, Takuma Shibata, Ryutaro Fukui, Yoichi Furukawa, Kenji Kabashima, Kensuke Miyake

    International immunology   2024.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    In sarcoidosis, granulomas develop in multiple organs including the liver and lungs. Although mTORC1 activation in macrophages drives granuloma development in sarcoidosis by enhancing macrophage proliferation, little is known about the macrophage subsets that proliferate and mature into granuloma macrophages. Here, we show that aberrantly increased monocytopoiesis gives rise to granulomas in a sarcoidosis model, in which Tsc2, a negative regulator of mTORC1, is conditionally deleted in CSF1R-expressing macrophages (Tsc2csf1rΔ mice). In Tsc2csf1rΔ mice, common myeloid progenitors (CMPs), granulocyte-monocyte progenitors (GMPs), common monocyte progenitors/monocyte progenitors (cMoPs/MPs), inducible monocyte progenitors (iMoPs), and Ly6Cint CX3CR1low CD14- immature monocytes (iMOs), but not monocyte-dendritic cell progenitors (MDPs) and common dendritic cell progenitors (CDPs), accumulated and proliferated in the spleen. Consistent with this, monocytes, neutrophils, and neutrophil-like monocytes increased in the spleens of Tsc2csf1rΔ mice, whereas dendritic cells did not. The adoptive transfer of splenic iMOs into wild-type mice gave rise to granulomas in the liver and lungs. In these target organs, iMOs matured into Ly6Chi classical monocytes/macrophages (cMOs). Giant macrophages (gMAs) also accumulated in the liver and lungs, which were similar to granuloma macrophages in expression of cell surface markers such as MerTK and SLAMF7. Furthermore, the gMA-specific genes were expressed in human macrophages from sarcoidosis skin lesions. These results suggest that mTORC1 drives granuloma development by promoting the proliferation of monocyte/neutrophil progenitors and iMOs predominantly in the spleen, and that proliferating iMOs mature into cMOs and then gMAs to give rise to granuloma after migration into the liver and lungs in sarcoidosis.

    DOI: 10.1093/intimm/dxad054

    PubMed

    researchmap

  • Identification of small compounds that inhibit multiple myeloma proliferation by targeting c-Maf transcriptional activity Reviewed

    Kenichi Asano, Kenta Kikuchi, Miki Takehara, Manami Ogasawara, Yuki Yoshioka, Kie Ohnishi, Ayaka Iwata, Shigeomi Shimizu, Masato Tanaka

    Biochemical and Biophysical Research Communications   684   149135 - 149135   2023.12

     More details

    Authorship:Lead author, Corresponding author   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.bbrc.2023.149135

    researchmap

  • Dysfunction of sinus macrophages in tumor‐bearing host induces resistance to immunotherapy Reviewed

    Toshiki Anami, Cheng Pan, Yukio Fujiwara, Yoshihiro Komohara, Hiromu Yano, Yoichi Saito, Masamichi Sugimoto, Daiko Wakita, Takanobu Motoshima, Yoji Murakami, Junji Yatsuda, Naofumi Takahashi, Shinya Suzu, Kenichi Asano, Koji Tamada, Tomomi Kamba

    Cancer Science   2023.11

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    Abstract

    Sinus macrophages in draining lymph nodes (DLNs) are involved in anti‐tumor immune reactions. CD169 (Sialoadhesin, Siglec‐1) is expressed on sinus macrophages and is considered a surrogate marker for the immunostimulatory phenotype of macrophages. In this study, the significance of sinus macrophages in immunotherapy was evaluated using mouse models. Treatment with anti‐programmed death‐ligand 1 (PD‐L1) antibody suppressed the subcutaneous tumor growth of MC38 and E0771 cells but was not effective against MB49 and LLC tumors. Decreased cytotoxic T‐lymphocyte (CTL) infiltration in tumor tissues and CD169 expression in sinus macrophages were observed in MB49 and LLC cells compared to corresponding parameters in MC38 and E0771 cells. The anti‐tumor effects of the anti‐PD‐L1 antibody on MC38 and E0771 cells were abolished when sinus macrophages in DLNs were depleted, suggesting that sinus macrophages are involved in the therapeutic effect of the anti‐PD‐L1 antibody. Naringin activated sinus macrophages. Naringin inhibited tumor growth in MB49‐ and LLC‐bearing mice but did not affect that in MC38‐ and E0771‐bearing mice. The infiltration of CTLs in tumor tissues and their activation were increased by naringin, and this effect was impaired when sinus macrophages were depleted. Combination therapy with naringin and anti‐PD‐L1 antibody suppressed MB49 tumor growth. In conclusion, CD169‐positive sinus macrophages in DLNs are critical for anti‐tumor immune responses, and naringin suppresses tumor growth by activating CD169‐positive sinus macrophages and anti‐tumor CTL responses. The activation status of sinus macrophages has been suggested to differ among tumor models, and this should be investigated in future studies.

    DOI: 10.1111/cas.16003

    researchmap

  • Zika virus spreads through infection of lymph node-resident macrophages. International journal

    Glennys V Reynoso, David N Gordon, Anurag Kalia, Cynthia C Aguilar, Courtney S Malo, Maya Aleshnick, Kimberly A Dowd, Christian R Cherry, John P Shannon, Sophia M Vrba, Autumn C Holmes, Yael Alippe, Sonia Maciejewski, Kenichi Asano, Michael S Diamond, Theodore C Pierson, Heather D Hickman

    Cell reports   42 ( 2 )   112126 - 112126   2023.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    To disseminate through the body, Zika virus (ZIKV) is thought to exploit the mobility of myeloid cells, in particular monocytes and dendritic cells. However, the timing and mechanisms underlying shuttling of the virus by immune cells remains unclear. To understand the early steps in ZIKV transit from the skin, at different time points, we spatially mapped ZIKV infection in lymph nodes (LNs), an intermediary site en route to the blood. Contrary to prevailing hypotheses, migratory immune cells are not required for the virus to reach the LNs or blood. Instead, ZIKV rapidly infects a subset of sessile CD169+ macrophages in the LNs, which release the virus to infect downstream LNs. Infection of CD169+ macrophages alone is sufficient to initiate viremia. Overall, our experiments indicate that macrophages that reside in the LNs contribute to initial ZIKV spread. These studies enhance our understanding of ZIKV dissemination and identify another anatomical site for potential antiviral intervention.

    DOI: 10.1016/j.celrep.2023.112126

    PubMed

    researchmap

  • Synaptic pruning of murine adult-born neurons by microglia depends on phosphatidylserine. Reviewed International journal

    Chihiro Kurematsu, Masato Sawada, Masaki Ohmuraya, Motoki Tanaka, Kazuya Kuboyama, Takashi Ogino, Mami Matsumoto, Hisashi Oishi, Hiroyuki Inada, Yuri Ishido, Yukina Sakakibara, Huy Bang Nguyen, Truc Quynh Thai, Shinichi Kohsaka, Nobuhiko Ohno, Maki K Yamada, Masato Asai, Masahiro Sokabe, Junichi Nabekura, Kenichi Asano, Masato Tanaka, Kazunobu Sawamoto

    The Journal of experimental medicine   219 ( 4 )   2022.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    New neurons, continuously added in the adult olfactory bulb (OB) and hippocampus, are involved in information processing in neural circuits. Here, we show that synaptic pruning of adult-born neurons by microglia depends on phosphatidylserine (PS), whose exposure on dendritic spines is inversely correlated with their input activity. To study the role of PS in spine pruning by microglia in vivo, we developed an inducible transgenic mouse line, in which the exposed PS is masked by a dominant-negative form of milk fat globule-EGF-factor 8 (MFG-E8), MFG-E8D89E. In this transgenic mouse, the spine pruning of adult-born neurons by microglia is impaired in the OB and hippocampus. Furthermore, the electrophysiological properties of these adult-born neurons are altered in MFG-E8D89E mice. These data suggest that PS is involved in the microglial spine pruning and the functional maturation of adult-born neurons. The MFG-E8D89E-based genetic approach shown in this study has broad applications for understanding the biology of PS-mediated phagocytosis in vivo.

    DOI: 10.1084/jem.20202304

    PubMed

    researchmap

  • CD169-positive macrophages enhance abscopal effect of radiofrequency ablation therapy in liver cancer. Reviewed International journal

    Xiaojia Song, Na Li, Yuan Liu, Zehua Wang, Tixiao Wang, Siyu Tan, Chunyang Li, Chunhong Qiu, Lifen Gao, Kenichi Asano, Masato Tanaka, Xiaohong Liang, Xinyong Liu, Chunhong Ma

    Translational oncology   15 ( 1 )   101306 - 101306   2022.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Radiofrequency ablation (RFA) is a widely used and effective treatment for primary or metastatic liver cancer with small-size lesions. However, the therapeutic effectiveness of RFA in controlling metastatic lesion or recurrence is still limited. As the major cell population in tumor microenvironment (TME), macrophages have been reported to be recruited to RFA-treated lesion, but their roles are still unclear. Herein, we successfully established the mouse model mimicking RFA-induced abscopal effect, in which RFA eliminated the local orthotopic liver tumor but failed to control growth of distant tumor. Correspondently, RFA suppressed protumoral activation of local tumor-associated macrophages (TAMs), but failed to reprogram TAMs in distance. Importantly, although RFA led to reduced proportion of hepatic CD169+ macrophages in local and decreased expression of immune inhibitory molecules Tim-3 and PD-L1, these alterations were not observed for CD169+ macrophages in distant TME. Further RNA-seq and flow cytometry analysis showed that hepatic CD169+ macrophages contributed to reprograming TME through recruiting CD8+ T/NK cells and suppressing accumulation of MDSCs/Tregs. Consistently, depletion of CD169+ macrophages in CD169-DTR mouse greatly promoted liver tumor progression and largely dampened RFA-induced tumor suppression. Notably, transfer of CD169+ macrophages synergistically enhanced RFA-induced inhibition of distant tumor. To our knowledge, this is the first study which demonstrates hepatic CD169+ macrophages as a key factor responsible for RFA-induced abscopal effect. Our data suggest RFA with transfer of CD169+ macrophages as a promising combination therapy to lessen metastasis or recurrence of liver cancer in patients.

    DOI: 10.1016/j.tranon.2021.101306

    PubMed

    researchmap

  • Pathogenic roles and therapeutic potential of the CCL8-CCR8 axis in a murine model of IgG4-related sialadenitis. Reviewed International journal

    Fumika Honda, Hiroto Tsuboi, Yuko Ono, Saori Abe, Hiroyuki Takahashi, Kiyoaki Ito, Kazunori Yamada, Mitsuhiro Kawano, Yuya Kondo, Kenichi Asano, Masato Tanaka, Marie Malissen, Bernard Malissen, Isao Matsumoto, Takayuki Sumida

    Arthritis research & therapy   23 ( 1 )   214 - 214   2021.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Our previous studies reveal that CCL18-CCR8 chemokine axis is upregulated in patients of immunoglobulin G4-related disease (IgG4-RD), suggesting that the CCL18-CCR8 axis is implicated in the etiology of IgG4-RD, although whether this axis has a potential as a therapeutic target remains unclear. Our purpose was to clarify the pathogenic roles and therapeutic potential of the murine CCL8 (analog of human CCL18)-CCR8 axis by using an animal model of IgG4-RD (LAT Y136F knockin mice; LAT mice). METHODS: We compared the infiltration of inflammatory cells and the fibrosis of the salivary glands of 6-week-old LAT mice and littermate mice. The expressions of Ccl8 and Ccr8 were also compared. Next, we investigated the therapeutic effects of intravenous administration of anti-CCL8 neutralizing antibody in LAT mice against inflammation and fibrosis of the salivary glands. We also investigated the effects of stimulation with recombinant mouse CCL8 on the collagen production in a mouse fibroblast cell line (NIH/3 T3) in vitro. RESULTS: When compared with the littermates, the LAT mice showed apparent infiltration of inflammatory cells and fibrosis in the salivary glands. The focus and fibrosis score in the salivary glands were significantly higher in the LAT mice than in the littermates. The expression levels of Ccl8 in the spleen and of Ccr8 in the salivary glands were significantly higher in the LAT mice than in the littermates. Anti-CCL8 antibody significantly improved the focus and fibrosis score in the salivary glands of the LAT mice. In vitro, stimulation with recombinant mouse CCL8 significantly increased the expression of collagen and ERK1/2 phosphorylation in NIH/3 T3. CONCLUSION: We clarified the overexpression and therapeutic potential of the mouse CCL8-CCR8 axis in LAT mice, which could play a crucial role in fibrosis via ERK1/2 phosphorylation, as well as the chemotaxis of inflammatory cells. The human CCL18-CCR8 axis might be a novel therapeutic target for IgG4-RD.

    DOI: 10.1186/s13075-021-02597-6

    PubMed

    researchmap

  • Anti-Cancer Immune Reaction and Lymph Node Macrophage; A Review from Human and Animal Studies Reviewed

    Yoshihiro Komohara, Toshiki Anami, Kenichi Asano, Yukio Fujiwara, Junji Yatsuda, Tomomi Kamba

    Immuno   1 ( 3 )   223 - 230   2021.7

     More details

    Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    Lymph nodes are secondary lymphoid organs that appear as bean-like nodules usually <1 cm in size, and they are localized throughout the body. Many antigen-presenting cells such as dendritic cells and macrophages reside in lymph nodes, where they mediate host defense responses against pathogens such as viruses and bacteria. In cancers, antigen-presenting cells induce cytotoxic T lymphocytes (CTLs) to react to cancer cell-derived antigens. Macrophages located in the lymph node sinus are of particular interest in relation to anti-cancer immune responses because many studies using both human specimens and animal models have suggested that lymph node macrophages expressing CD169 play a key role in activating anti-cancer CTLs. The regulation of lymph node macrophages therefore represents a potentially promising novel approach in anti-cancer therapy.

    DOI: 10.3390/immuno1030014

    researchmap

  • Deletion of Alox15 improves kidney dysfunction and inhibits fibrosis by increased PGD2 in the kidney. Reviewed

    Naohiro Takahashi, Hiroaki Kikuchi, Ayaka Usui, Taisuke Furusho, Takuya Fujimaru, Tamami Fujiki, Tomoki Yanagi, Yoshiaki Matsuura, Kenichi Asano, Kouhei Yamamoto, Fumiaki Ando, Koichiro Susa, Shintaro Mandai, Takayasu Mori, Tatemitsu Rai, Shinichi Uchida, Makoto Arita, Eisei Sohara

    Clinical and experimental nephrology   25 ( 5 )   445 - 455   2021.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Lipid-metabolizing enzymes and their metabolites affect inflammation and fibrosis, but their roles in chronic kidney disease (CKD) have not been completely understood. METHODS: To clarify their role in CKD, we measured the mRNA levels of major lipid-metabolizing enzymes in 5/6 nephrectomized (Nx) kidneys of C57BL/6 J mice. Mediator lipidomics was performed to reveal lipid profiles of CKD kidneys. RESULTS: In 5/6 Nx kidneys, both mRNA and protein levels of Alox15 were higher when compared with those in sham kidneys. With respect to in situ hybridization, the mRNA level of Alox15 was higher in renal tubules of 5/6 Nx kidneys. To examine the role of Alox15 in CKD pathogenesis, we performed 5/6 Nx on Alox15-/- mice. Alox15-/- CKD mice exhibited better renal functions than wild-type mice. Interstitial fibrosis was also inhibited in Alox15-/- CKD mice. Mediator lipidomics revealed that Alox15-/- CKD mouse kidneys had significantly higher levels of PGD2 than the control. To investigate the effects of PGD2 on renal fibrosis, we administered PGD2 to TGF-β1-stimulated NRK-52E cells and HK-2 cells, which lead to a dose-dependent suppression of type I collagen and αSMA in both cell lines. CONCLUSION: Increased PGD2 in Alox15-/- CKD mouse kidneys could inhibit fibrosis, thereby resulting in CKD improvement. Thus, Alox15 inhibition and PGD2 administration may be novel therapeutic targets for CKD.

    DOI: 10.1007/s10157-021-02021-y

    PubMed

    researchmap

  • WNK1-TAK1 signaling suppresses lipopolysaccharide-induced cytokine production and classical activation in macrophages. Reviewed International journal

    Yohei Arai, Kenichi Asano, Shintaro Mandai, Fumiaki Ando, Koichiro Susa, Takayasu Mori, Naohiro Nomura, Tatemitsu Rai, Masato Tanaka, Shinichi Uchida, Eisei Sohara

    Biochemical and biophysical research communications   533 ( 4 )   1290 - 1297   2020.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    With-no-lysine kinase (WNK) plays important roles in regulating electrolyte homeostasis, cell signaling, survival, and proliferation. It has been recently demonstrated that WNK1, a member of the WNK family, modifies the function of immune cells. Here we report that in macrophages, WNK1 has suppressive effects on lipopolysaccharide (LPS)-induced inflammatory responses via TGFβ-activated kinase 1 (TAK1)-mediated activation of nuclear factor-kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathway. We found that WNK1 heterozygous (WNK1+/-) mice produced excessive proinflammatory cytokines in an experimental LPS-induced sepsis model, and peritoneal macrophages isolated from WNK1+/- mice produced higher levels of LPS-induced cytokines and NOS2 expression as canonical proinflammatory M1 macrophage markers. We confirmed that small hairpin RNA (shRNA)-mediated knockdown of WNK1 activated LPS-induced cytokine production and NOS2 expression in RAW 264.7 macrophages. Moreover, we demonstrated that WNK1 knockdown increased the nuclear translocation of NF-κB and activated the p38 and Jun N-terminal kinase (JNK) MAPK signaling pathway and that a TAK1 inhibitor diminished these effects of WNK1 knockdown. These results suggest that WNK1 acts as a physiologic immune modulator via interactions with TAK1. WNK1 may be a therapeutic target against the cytokine storm caused by sepsis.

    DOI: 10.1016/j.bbrc.2020.10.007

    PubMed

    researchmap

  • Corrigendum to: "CD204-positive monocytes and macrophages ameliorate septic shock by suppressing proinflammatory cytokine production in mice". International journal

    Yoshimi Uchida, Gen Nishitai, Kenta Kikuchi, Takumi Shibuya, Kenichi Asano, Masato Tanaka

    Biochemistry and biophysics reports   24   100810 - 100810   2020.12

     More details

    Language:English  

    [This corrects the article DOI: 10.1016/j.bbrep.2020.100791.].

    DOI: 10.1016/j.bbrep.2020.100810

    PubMed

    researchmap

  • CD204-positive monocytes and macrophages ameliorate septic shock by suppressing proinflammatory cytokine production in mice. Reviewed International journal

    Yoshimi Uchida, Gen Nishitai, Kenta Kikuchi, Takumi Shibuya, Kenichi Asano, Masato Tanaka

    Biochemistry and biophysics reports   23   100791 - 100791   2020.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Sepsis is defined as a life-threatening multiorgan dysfunction caused by dysregulated inflammatory response to infection. It remains the primary cause of death from infection if not diagnosed and treated promptly. Therefore, a better understanding of the mechanism for resolving inflammation is needed. Monocytes and macrophages play a pivotal role not only in the induction but also in the suppression of inflammation. However, a tissue-resident macrophage subset that regulates a hyperinflammatory state during sepsis has not been explored. Here we show that CD204+ monocytes and/or macrophages rescued mice from endotoxin-induced septic shock. Serum and tissue proinflammatory cytokine levels were significantly upregulated in the absence of these cells. This study provided evidence that CD204+ monocytes and/or macrophages ameliorate septic shock by suppressing proinflammatory cytokine production.

    DOI: 10.1016/j.bbrep.2020.100791

    PubMed

    researchmap

  • Vitamin E Scaffolds of pH-Responsive Lipid Nanoparticles as DNA Vaccines in Cancer and Protozoan Infection. Reviewed International journal

    Mio Maeta, Naoya Miura, Hiroki Tanaka, Takashi Nakamura, Ryo Kawanishi, Yoshifumi Nishikawa, Kenichi Asano, Masato Tanaka, Shinya Tamagawa, Yuta Nakai, Kota Tange, Hiroki Yoshioka, Hideyoshi Harashima, Hidetaka Akita

    Molecular pharmaceutics   17 ( 4 )   1237 - 1247   2020.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DNA vaccinations are promising strategies for treating diseases that require cellular immunity (i.e., cancer and protozoan infection). Here, we report on the use of a liposomal nanocarrier (lipid nanoparticles (LNPs)) composed of an SS-cleavable and pH-activated lipidlike material (ssPalm) as an in vivo DNA vaccine. After subcutaneous administration, the LNPs containing an ssPalmE, an ssPalm with vitamin E scaffolds, elicited a higher gene expression activity in comparison with the other LNPs composed of the ssPalms with different hydrophobic scaffolds. Immunization with the ssPalmE-LNPs encapsulating plasmid DNA that encodes ovalbumin (OVA, a model tumor antigen) or profilin (TgPF, a potent antigen of Toxoplasma gondii) induced substantial antitumor or antiprotozoan effects, respectively. Flow cytometry analysis of the cells that had taken up the LNPs in draining lymph nodes (dLNs) showed that the ssPalmE-LNPs were largely taken up by macrophages and a small number of dendritic cells. We found that the transient deletion of CD169+ macrophages, a subpopulation of macrophages that play a key role in cancer immunity, unexpectedly enhanced the activity of the DNA vaccine. These data suggest that the ssPalmE-LNPs are effective DNA vaccine carriers, and a strategy for avoiding their being trapped by CD169+ macrophages will be a promising approach for developing next-generation DNA vaccines.

    DOI: 10.1021/acs.molpharmaceut.9b01262

    PubMed

    researchmap

  • MT1-MMP recruits the ER-Golgi SNARE Bet1 for efficient MT1-MMP transport to the plasma membrane. Reviewed International journal

    Takuya Miyagawa, Kana Hasegawa, Yoko Aoki, Takuya Watanabe, Yuka Otagiri, Kohei Arasaki, Yuichi Wakana, Kenichi Asano, Masato Tanaka, Hideki Yamaguchi, Mitsuo Tagaya, Hiroki Inoue

    The Journal of cell biology   218 ( 10 )   3355 - 3371   2019.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Metastasis is a major cause of cancer-related death. Membrane type 1-matrix metalloproteinase (MT1-MMP) is a critical protease for local invasion and metastasis. MT1-MMP is synthesized in the endoplasmic reticulum (ER) and transported in vesicles to invadopodia, specialized subdomains of the plasma membrane, through secretory and endocytic recycling pathways. The molecular mechanism underlying intracellular transport of MT1-MMP has been extensively studied, but is not fully understood. We show that MT1-MMP diverts the SNARE Bet1 from its function in ER-Golgi transport, to promote MT1-MMP trafficking to the cell surface, likely to invadopodia. In invasive cells, Bet1 is localized in MT1-MMP-positive endosomes in addition to the Golgi apparatus, and forms a novel SNARE complex with syntaxin 4 and endosomal SNAREs. MT1-MMP may also use Bet1 for its export from raft-like structures in the ER. Our results suggest the recruitment of Bet1 at an early stage after MT1-MMP expression promotes the exit of MT1-MMP from the ER and its efficient transport to invadopodia.

    DOI: 10.1083/jcb.201808149

    PubMed

    researchmap

  • Development of a Water-Soluble Indolylmaleimide Derivative IM-93 Showing Dual Inhibition of Ferroptosis and NETosis. Reviewed International journal

    Kosuke Dodo, Erika Kuboki, Tadashi Shimizu, Ryu Imamura, Megumi Magarisawa, Masahiro Takahashi, Takuto Tokuhiro, Satoshi Yotsumoto, Kenichi Asano, Shuhei Nakao, Naoki Terayama, Takashi Suda, Masato Tanaka, Mikiko Sodeoka

    ACS medicinal chemistry letters   10 ( 9 )   1272 - 1278   2019.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The indolylmaleimide (IM) derivative IM-17 shows inhibitory activity against oxidative-stress-induced necrotic cell death and cardioprotective activity in rat ischemia-reperfusion injury models. In order to develop a more potent derivative, we conducted a detailed structure-activity relationship study of IM derivatives and identified IM-93 as the most potent derivative with good water solubility. IM-93 inhibited ferroptosis and NETosis, but not necroptosis or pyroptosis. In contrast, ferrostatin-1 (Fer-1), a ferroptosis inhibitor, did not inhibit NETosis, although the accompanying lipid peroxidation was partially inhibited by Fer-1, as well as by IM-93. Thus, IM derivatives have a unique activity profile and appear to be promising candidates for in vivo application.

    DOI: 10.1021/acsmedchemlett.9b00142

    PubMed

    researchmap

  • Lymph Node Mesenchymal and Endothelial Stromal Cells Cooperate via the RANK-RANKL Cytokine Axis to Shape the Sinusoidal Macrophage Niche. Reviewed International journal

    Abdouramane Camara, Olga G Cordeiro, Farouk Alloush, Janina Sponsel, Mélanie Chypre, Lucas Onder, Kenichi Asano, Masato Tanaka, Hideo Yagita, Burkhard Ludewig, Vincent Flacher, Christopher G Mueller

    Immunity   50 ( 6 )   1467 - 1481   2019.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Tissue-resident macrophages are receptive to specific signals concentrated in cellular niches that direct their cell differentiation and maintenance genetic programs. Here, we found that deficiency of the cytokine RANKL in lymphoid tissue organizers and marginal reticular stromal cells of lymph nodes resulted in the loss of the CD169+ sinusoidal macrophages (SMs) comprising the subcapsular and the medullary subtypes. Subcapsular SM differentiation was impaired in mice with targeted RANK deficiency in SMs. Temporally controlled RANK removal in lymphatic endothelial cells (LECs) revealed that lymphatic RANK activation during embryogenesis and shortly after birth was required for the differentiation of both SM subtypes. Moreover, RANK expression by LECs was necessary for SM restoration after inflammation-induced cell loss. Thus, cooperation between mesenchymal cells and LECs shapes a niche environment that supports SM differentiation and reconstitution after inflammation.

    DOI: 10.1016/j.immuni.2019.05.008

    PubMed

    researchmap

  • Maf expression in human macrophages and lymph node sinus macrophages in patients with esophageal cancer. Reviewed

    Hiroto Takeya, Koji Ohnishi, Takuya Shiota, Yoichi Saito, Yukio Fujiwara, Taisuke Yagi, Yuki Kiyozumi, Yoshifumi Baba, Naoya Yoshida, Kenichi Asano, Masato Tanaka, Hideo Baba, Yoshihiro Komohara

    Journal of clinical and experimental hematopathology : JCEH   59 ( 3 )   112 - 118   2019

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The large Maf transcription factors are expressed in immune cells including macrophages and lymphocytes. To investigate the distribution of Maf expression in human organs, immunostaining for Maf was performed using sections of several human organs. High Maf expression was seen in the nucleus of macrophages in the gastrointestinal tract and lymph node sinus macrophages (LySMs). Then, we assessed whether Maf expression in LySMs was correlated with CD169 expression and the clinical prognosis in patients with esophageal cancer. Maf expression was associated with CD169 expression, but Maf expression in LySMs was not associated with the clinical course in patients with esophageal cancer. We determined which cytokines stimulate Maf expression using cultured macrophages. Immunocytochemistry showed that Maf expression was significantly elevated by interferon-γ. These results are the first report of Maf expression in human samples. Maf expression may be a marker for the macrophage population in humans.

    DOI: 10.3960/jslrt.19002

    PubMed

    researchmap

  • Generation of and characterization of anti-IL-11 antibodies using newly established Il11-deficient mice. Reviewed International journal

    Yutaka Deguchi, Takashi Nishina, Kenichi Asano, Masaki Ohmuraya, Yoshiko Nakagawa, Naomi Nakagata, Tetsushi Sakuma, Takashi Yamamoto, Kimi Araki, Tetuo Mikami, Masato Tanaka, Hiroyasu Nakano

    Biochemical and biophysical research communications   505 ( 2 )   453 - 459   2018.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Interleukin (IL)-11 belongs to the members of the IL-6 family of cytokines and is involved in a variety of biological responses, including hematopoiesis, bone development, and carcinogenesis. However, the cellular sources of IL-11 and regulation of IL-11 expression under physiological and pathological conditions are not fully understood. One of the causes to prevent characterization of IL-11 in vivo is due to the lack of reliable antibodies that detect IL-11 by immunohistochemistry. Moreover, although mice lacking Il11ra have been generated and extensively characterized, Il11-deficient mice have not been characterized yet. Here we generated two anti-IL-11 antibodies that blocked biological activities of IL-11 and detected IL-11 by immunohistochemistry, respectively. One clone of anti-IL-11 antibodies blocked IL-11-, but not IL-6-induced cell proliferation and IL-11-induced phosphorylation of STAT3 of an IL-11-dependent cell line. Moreover, we used recently established Il11-deficient mice to test the specificity of anti-IL-11 antibodies for immunohistochemistry. Another clone of anti-IL-11 antibodies stained stromal cells surrounding tumors of the colon of wild-type, but not Il11-deficient mice following treatment with Azoxymethane plus dextran sulfate sodium. Together, these newly developed anti-IL-11 antibodies provide a better understanding of the functions of IL-11 in vivo under various physiological and pathological conditions.

    DOI: 10.1016/j.bbrc.2018.09.128

    PubMed

    researchmap

  • CD169 macrophages regulate immune responses toward particulate materials in the circulating fluid. Reviewed International journal

    Kenichi Asano, Kenta Kikuchi, Masato Tanaka

    Journal of biochemistry   164 ( 2 )   77 - 85   2018.8

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Tissue macrophages comprise heterogeneous subsets that differ in localization, phenotype and ontogeny. They acquire tissue-specific phenotype in order to maintain normal tissue physiology. This review summarizes the current knowledge about the functions of CD169-positive macrophage subset residing in the lymphoid organs and intestinal tract. Strategically positioned at the interface between tissue and circulating fluid, CD169+ macrophages in the lymphoid organs capture blood- and lymph-borne particulate materials. Antigen information relayed by CD169+ macrophages to neighbouring immune cells is important for enhancement of antimicrobial and antitumour immunity as well as induction of tolerance. In the intestinal tract, CD169+ macrophages localize distantly from epithelial border. Following mucosal injury, they exacerbate inflammation by producing CCL8 that recruits inflammatory monocytes. As such, a better understanding of CD169+ macrophage phenotypes may enable the design of tissue-specific therapies for both immunological and non-immunological diseases.

    DOI: 10.1093/jb/mvy050

    PubMed

    researchmap

  • WNK1はマクロファージにおいてLPS誘導性サイトカイン産生を抑制する Reviewed

    新井 洋平, 蘇原 映誠, 浅野 謙一, 田中 正人, 頼 建光, 内田 信一

    日本腎臓学会誌   60 ( 3 )   335 - 335   2018.4

     More details

    Language:Japanese   Publisher:(一社)日本腎臓学会  

    researchmap

  • CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis. Reviewed International journal

    Michiko Itoh, Takayoshi Suganami, Hideaki Kato, Sayaka Kanai, Ibuki Shirakawa, Takeru Sakai, Toshihiro Goto, Masahiro Asakawa, Isao Hidaka, Hiroshi Sakugawa, Koji Ohnishi, Yoshihiro Komohara, Kenichi Asano, Isao Sakaida, Masato Tanaka, Yoshihiro Ogawa

    JCI insight   2 ( 22 )   2017.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Although recent evidence has pointed to the role of organ- and pathogenesis-specific macrophage subsets, it is still unclear which subsets are critically involved in the pathogenesis of nonalcoholic steatohepatitis (NASH). Using melanocortin-4 receptor-deficient (MC4R-KO) mice fed Western diet (WD), which exhibit liver phenotypes similar to those of human NASH, we found a histological structure, termed hepatic crown-like structure (hCLS), in which CD11c+ macrophages surround dead/dying hepatocytes, a prominent feature of NASH. Here, we demonstrate that hCLS-constituting macrophages could be a novel macrophage subset that drives hepatocyte death-triggered liver fibrosis. In an "inducible NASH model," hepatocyte death induces hCLS formation and liver fibrosis sequentially in the short term. In combination with the long-term WD feeding model, we also showed that resident macrophages are a major cellular source of CD11c+ macrophages constituting hCLS, which exhibited gene expression profiles distinct from CD11c- macrophages scattered in the liver. Moreover, depletion of CD11c+ macrophages abolished hCLS formation and fibrogenesis in NASH. Our clinical data suggest the role of CD11c+ macrophages in the disease progression from simple steatosis to NASH. This study sheds light on the role of resident macrophages, in addition to recruited macrophages, in the pathogenesis of NASH.

    DOI: 10.1172/jci.insight.92902

    PubMed

    researchmap

  • Salt suppresses IFNγ inducible chemokines through the IFNγ-JAK1-STAT1 signaling pathway in proximal tubular cells. Reviewed International journal

    Yohei Arai, Daiei Takahashi, Kenichi Asano, Masato Tanaka, Mayumi Oda, Shigeru B H Ko, Minoru S H Ko, Shintaro Mandai, Naohiro Nomura, Tatemitsu Rai, Shinichi Uchida, Eisei Sohara

    Scientific reports   7   46580 - 46580   2017.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The mechanisms of immunoactivation by salt are now becoming clearer. However, those of immunosuppression remain unknown. Since clinical evidence indicates that salt protects proximal tubules from injury, we investigated mechanisms responsible for salt causing immunosuppression in proximal tubules. We focused on cytokine-related gene expression profiles in kidneys of mice fed a high salt diet using microarray analysis and found that both an interferon gamma (IFNγ) inducible chemokine, chemokine (C-X-C motif) ligand 9 (CXCL9), and receptor, CXCR3, were suppressed. We further revealed that a high salt concentration suppressed IFNγ inducible chemokines in HK2 proximal tubular cells. Finally, we demonstrated that a high salt concentration decreased IFNGR1 expression in the basolateral membrane of HK2 cells, leading to decreased phosphorylation of activation sites of Janus kinase 1 (JAK1) and Signal Transducers and Activator of Transcription 1 (STAT1), activators of chemokines. JAK inhibitor canceled the effect of a high salt concentration on STAT1 and chemokines, indicating that the JAK1-STAT1 signaling pathway is essential for this mechanism. In conclusion, a high salt concentration suppresses IFNγ-JAK1-STAT1 signaling pathways and chemokine expressions in proximal tubules. This finding may explain how salt ameliorates proximal tubular injury and offer a new insight into the linkage between salt and immunity.

    DOI: 10.1038/srep46580

    PubMed

    researchmap

  • 塩は近位尿細管細胞においてJAK/STAT系を介してINFgamma関連ケモカインを抑制する Reviewed

    新井 洋平, 蘇原 映誠, 高橋 大栄, 浅野 謙一, 田中 正人, 小田 真由美, 洪 繁, 洪 実, 萬代 新太郎, 野村 尚弘, 頼 建光, 内田 信一

    日本腎臓学会誌   59 ( 3 )   231 - 231   2017.4

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:(一社)日本腎臓学会  

    researchmap

  • WNK1はマクロファージにおけるLPS誘導性サイトカイン産生を抑制する Reviewed

    新井 洋平, 蘇原 映誠, 浅野 謙一, 田中 正人, 頼 建光, 内田 信一

    日本腎臓学会誌   59 ( 3 )   281 - 281   2017.4

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:(一社)日本腎臓学会  

    researchmap

  • Regulation of B cell differentiation by the ubiquitin-binding protein TAX1BP1. Reviewed International journal

    Nobuko Matsushita, Midori Suzuki, Emi Ikebe, Shun Nagashima, Ryoko Inatome, Kenichi Asano, Masato Tanaka, Masayuki Matsushita, Eisaku Kondo, Hidekatsu Iha, Shigeru Yanagi

    Scientific reports   6   31266 - 31266   2016.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Tax1-binding protein 1 (TAX1BP1) is a ubiquitin-binding protein that restricts nuclear factor-κB (NF-κB) activation and facilitates the termination of aberrant inflammation. However, its roles in B-cell activation and differentiation are poorly understood. To evaluate the function of TAX1BP1 in B cells, we established TAX1BP1-deficient DT40 B cells that are hyper-responsive to CD40-induced extracellular signal-regulated kinase (ERK) activation signaling, exhibit prolonged and exaggerated ERK phosphorylation and show enhanced B lymphocyte-induced maturation protein 1 (Blimp-1; a transcription factor inducing plasma cell differentiation) expression that is ERK-dependent. Furthermore, TAX1BP1-deficient cells exhibit significantly decreased surface IgM expression and increased IgM secretion. Moreover, TAX1BP1-deficient mice display reduced germinal center formation and antigen-specific antibody production. These findings show that TAX1BP1 restricts ERK activation and Blimp-1 expression and regulates germinal center formation.

    DOI: 10.1038/srep31266

    PubMed

    researchmap

  • γ-SNAP stimulates disassembly of endosomal SNARE complexes and regulates endocytic trafficking pathways. Reviewed International journal

    Hiroki Inoue, Yuka Matsuzaki, Ayaka Tanaka, Kaori Hosoi, Kaoru Ichimura, Kohei Arasaki, Yuichi Wakana, Kenichi Asano, Masato Tanaka, Daisuke Okuzaki, Akitsugu Yamamoto, Katsuko Tani, Mitsuo Tagaya

    Journal of cell science   128 ( 15 )   2781 - 94   2015.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) that reside in the target membranes and transport vesicles assemble into specific SNARE complexes to drive membrane fusion. N-ethylmaleimide-sensitive factor (NSF) and its attachment protein, α-SNAP (encoded by NAPA), catalyze disassembly of the SNARE complexes in the secretory and endocytic pathways to recycle them for the next round of fusion events. γ-SNAP (encoded by NAPG) is a SNAP isoform, but its function in SNARE-mediated membrane trafficking remains unknown. Here, we show that γ-SNAP regulates the endosomal trafficking of epidermal growth factor (EGF) receptor (EGFR) and transferrin. Immunoprecipitation and mass spectrometry analyses revealed that γ-SNAP interacts with a limited range of SNAREs, including endosomal ones. γ-SNAP, as well as α-SNAP, mediated the disassembly of endosomal syntaxin-7-containing SNARE complexes. Overexpression and small interfering (si)RNA-mediated depletion of γ-SNAP changed the morphologies and intracellular distributions of endosomes. Moreover, the depletion partially suppressed the exit of EGFR and transferrin from EEA1-positive early endosomes to delay their degradation and uptake. Taken together, our findings suggest that γ-SNAP is a unique SNAP that functions in a limited range of organelles - including endosomes - and their trafficking pathways.

    DOI: 10.1242/jcs.158634

    PubMed

    researchmap

  • The physiological roles of dead cell clearance. Reviewed

    Masato Tanaka, Kenichi Asano

    Nihon rinsho. Japanese journal of clinical medicine   73 Suppl 5   573 - 7   2015.6

     More details

    Authorship:Last author   Language:Japanese   Publishing type:Research paper (scientific journal)  

    PubMed

    researchmap

  • Colony-stimulating factor-1 signaling suppresses renal crystal formation. Reviewed International journal

    Kazumi Taguchi, Atsushi Okada, Hiroshi Kitamura, Takahiro Yasui, Taku Naiki, Shuzo Hamamoto, Ryosuke Ando, Kentaro Mizuno, Noriyasu Kawai, Keiichi Tozawa, Kenichi Asano, Masato Tanaka, Ichiro Miyoshi, Kenjiro Kohri

    Journal of the American Society of Nephrology : JASN   25 ( 8 )   1680 - 97   2014.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We recently reported evidence suggesting that migrating macrophages (Mϕs) eliminate renal crystals in hyperoxaluric mice. Mϕs can be inflammatory (M1) or anti-inflammatory (M2), and colony-stimulating factor-1 (CSF-1) mediates polarization to the M2Mϕ phenotype. M2Mϕs promote renal tissue repair and regeneration, but it is not clear whether these cells are involved in suppressing renal crystal formation. We investigated the role of M2Mϕs in renal crystal formation during hyperoxaluria using CSF-1-deficient mice, which lack M2Mϕs. Compared with wild-type mice, CSF-1-deficient mice had significantly higher amounts of renal calcium oxalate crystal deposition. Treatment with recombinant human CSF-1 increased the expression of M2-related genes and markedly decreased the number of renal crystals in both CSF-1-deficient and wild-type mice. Flow cytometry of sorted renal Mϕs showed that CSF-1 deficiency resulted in a smaller population of CD11b(+)F4/80(+)CD163(+)CD206(hi) cells, which represent M2-like Mϕs. Additionally, transfusion of M2Mϕs into CSF-1-deficient mice suppressed renal crystal deposition. In vitro phagocytosis assays with calcium oxalate monohydrate crystals showed a higher rate of crystal phagocytosis by M2-polarized Mϕs than M1-polarized Mϕs or renal tubular cells. Gene array profiling showed that CSF-1 deficiency resulted in disordered M2- and stone-related gene expressions. Collectively, our results provide compelling evidence for a suppressive role of CSF-1 signaling in renal crystal formation.

    DOI: 10.1681/ASN.2013060675

    PubMed

    researchmap

  • Immune regulation by apoptotic cell clearance. Reviewed International journal

    Masato Tanaka, Kenichi Asano, Chun-Hong Qiu

    Annals of the New York Academy of Sciences   1209   37 - 42   2010.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Apoptotic cell clearance by phagocytes is essential for the maintenance of self-tolerance under physiological conditions. Consistent with this, the intravenous injection of apoptotic cells can induce cell-associated antigen-specific immunosuppression or tolerance. The intravenous injection of apoptotic cells expressed a fragment of myelin oligodendrocyte glycoprotein (MOG)-induced MOG-specific T cell tolerance and suppressed the development of experimental autoimmune encephalomyelitis. However, the suppressive effects of the MOG-expressing apoptotic cells were largely eliminated by masking phosphatidylserine (PS) exposed on the apoptotic cells, suggesting that the PS-dependent engulfment of apoptotic cells is required for the tolerance induction. We found that this mechanism of tolerance induction requires the contribution of two cell populations in the splenic marginal zone (MZ). The MZ contains two types of macrophages: marginal metallophilic macrophages and MZ macrophages. These macrophages contribute to the rapid clearance of cell corpses in blood flow. In addition, we also found that CD8α(+), CD103(+) dendritic cells localizing in the MZ selectively phagocytose blood-borne dead cells and subsequently present dead cell-associated antigens to induce antigen-specific immunosuppression or tolerance.

    DOI: 10.1111/j.1749-6632.2010.05746.x

    PubMed

    researchmap

  • xCT deficiency accelerates chemically induced tumorigenesis. Reviewed International journal

    Ami Nabeyama, Ai Kurita, Kenichi Asano, Yasunobu Miyake, Takuwa Yasuda, Ikuo Miura, Gen Nishitai, Satoko Arakawa, Shigeomi Shimizu, Shigeharu Wakana, Hisahiro Yoshida, Masato Tanaka

    Proceedings of the National Academy of Sciences of the United States of America   107 ( 14 )   6436 - 41   2010.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    During the course of inflammation and its resolution, macrophages are exposed to various cytotoxic materials, including reactive oxygen species. Thus, macrophages require a protective machinery against oxidative stress to survive at the inflammatory site. Here, we showed that xCT, a component of transport system x(c)(-), was significantly up-regulated in activated infiltrating cells, including macrophages and neutrophils at the inflammatory site. System x(c)(-) mediates the uptake of extracellular L-cystine and is consequently responsible for maintenance of intracellular glutathione levels. We established a loss-of-function mouse mutant line of xCT by N-ethyl-N-nitrosourea mutagenesis. Macrophages from xCT(mu/mu) mice showed cell death in association with the excessive release of high mobility group box chromosomal protein 1 upon stimulation with LPS, suggesting that xCT deficiency causes unremitting inflammation because of the impaired survival of activated macrophages at the inflammatory site. Subcutaneous injection of 3-methylcholanthrene (3-MCA) induced the generation of fibrosarcoma in association with inflammation. When 3-MCA was injected s.c. into mice, xCT mRNA was up-regulated in situ. In xCT(mu/mu) mice, inflammatory cytokines (such as IL-1beta and TNFalpha) were overexpressed, and the generation of 3-MCA-induced fibrosarcoma was accelerated. These results clearly indicate that the defect of the protective system against oxidative stress impaired survival of activated macrophages and subsequently enhanced tumorigenecity.

    DOI: 10.1073/pnas.0912827107

    PubMed

    researchmap

  • Adiponectin inhibits allograft rejection in murine cardiac transplantation. Reviewed International journal

    Yoshihisa Okamoto, Thomas Christen, Koichi Shimizu, Kenichi Asano, Shinji Kihara, Richard N Mitchell, Peter Libby

    Transplantation   88 ( 7 )   879 - 83   2009.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Low levels of plasma adiponectin, an adipocytokine that possesses anti-inflammatory and antiatherogenic properties, frequently observed among obese subjects correlate with higher prevalence of several cardiovascular diseases. This study investigated whether adiponectin modulates allograft rejection in major histocompatibility complex class II-mismatched cardiac transplants. METHODS: We heterotopically transplanted Bm12 allografts into adiponectin-deficient (APN-/-, C57BL/6 background) or wild-type (APN+/+) mice. Some APN-/- mice received adiponectin reconstitution by adenovirus. Histologic analyses assessed allograft rejection, and real-time reverse-transcriptase polymerase chain reaction evaluated the genes for cytokines/chemokines associated with the immune and inflammatory responses. In addition, we tested the effect of adiponectin on proliferation and cytokine/chemokine production in mouse T lymphocytes stimulated in vitro with anti-CD3 antibodies. RESULTS: Allografts transplanted to APN-/- mice showed severe acute rejection relative to transplants in APN+/+ hosts accompanied by increased accumulation of CD4- and CD8-positive T lymphocytes and Mac3-positive macrophages. Adiponectin provision by adenovirus in APN-/- mice reversed these exacerbated responses to allografting. The rejected allografts in APN-/- mice contained significantly higher levels of tumor necrosis factor-alpha, interferon-gamma, and regulated on activation normal t expressed and presumably secreted. Moreover, adiponectin significantly suppressed proliferation and production of tumor necrosis factor-alpha, interferon-gamma, regulated on activation normal t expressed and presumably secreted, monocyte chemotactic protein-1, and interferon-gamma inducible protein-10 in mouse T lymphocytes stimulated in vitro with anti-CD3 antibodies. CONCLUSIONS: These observations provide new mechanistic insight into immunoregulation in allograft recipients relative to obesity, an increasingly prevalent risk factor. Adiponectin may offer a new therapeutic target for allograft rejection after cardiac transplantation.

    DOI: 10.1097/TP.0b013e3181b6efbf

    PubMed

    researchmap

  • Role of TNF priming and adhesion molecules in neutrophil recruitment to intravascular immune complexes. Reviewed International journal

    Michael Lauterbach, Peter O'Donnell, Kenichi Asano, Tanya N Mayadas

    Journal of leukocyte biology   83 ( 6 )   1423 - 30   2008.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Neutrophils play an important role in immune complex (IC)-mediated diseases, but the mechanisms underlying their recruitment to sites of IC deposition remain largely undefined. Furthermore, neutrophils encounter cytokines that prime their effector functions, yet the physiological relevance of priming to neutrophil functions is unclear. Using intravital microscopy, we demonstrate that TNF treatment of neutrophils ex vivo significantly increased their adhesion in a model of intravascular ICs deposited in the cremaster muscle. Notably, TNF priming had no effect on neutrophil adhesion in the absence of ICs. Analyses of relevant knockout mice and neutrophil reconstitution revealed a critical role for FcgammaRs and the CD18 integrin Mac-1 in IC-mediated neutrophil adhesion. Furthermore, ICAM-1, a major Mac-1 ligand constitutively expressed on unactivated endothelium, significantly contributed to this process. These data suggest that TNF priming promotes FcgammaR interaction with intravascular ICs, leading to the binding of Mac-1 to ICAM-1 and subsequent neutrophil arrest.

    DOI: 10.1189/jlb.0607421

    PubMed

    researchmap

  • Requirement for Vav proteins in post-recruitment neutrophil cytotoxicity in IgG but not complement C3-dependent injury. International journal

    Ahmad Utomo, Junichi Hirahashi, Divya Mekala, Kenichi Asano, Michael Glogauer, Xavier Cullere, Tanya N Mayadas

    Journal of immunology (Baltimore, Md. : 1950)   180 ( 9 )   6279 - 87   2008.5

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    The signals linking neutrophil opsonic receptors, FcgammaRs and complement receptor 3 (Mac-1) to cellular cytotoxic responses are poorly understood. Furthermore, because a deficiency in activating FcgammaRs reduces both IgG-mediated neutrophil recruitment and tissue injury, the role of FcgammaRs specifically in mediating neutrophil cytotoxicity in vivo remains unclear. In this study, we demonstrate that neutrophil Vav 1 and 3, guanine exchange factors for Rac GTPases, are required for IgG/FcgammaR-mediated hemorrhage and edema in the reverse passive Arthus in the lung and skin. Rac GTPases are also required for development of the reverse passive Arthus reaction. A deficiency in Vav 1 and 3 does not affect neutrophil accumulation at the site of immune complex deposition, thus uncoupling neutrophil recruitment and tissue injury. Surprisingly, Vav and Rac proteins are dispensable for the development of the local Shwartzman reaction in vivo and phagocytosis of complement-opsonized RBC in vitro, processes strictly dependent on Mac-1 and complement C3. Thus, FcgammaR signaling through the Vav and Rac proteins in neutrophils is critical for stimulating immune complex disease while Vav- and Rac-independent pathways promote Mac-1/complement C3-dependent functions.

    PubMed

    researchmap

  • Leukocyte integrin Mac-1 promotes acute cardiac allograft rejection. Reviewed International journal

    Koichi Shimizu, Peter Libby, Rica Shubiki, Masashi Sakuma, Yunmei Wang, Kenichi Asano, Richard N Mitchell, Daniel I Simon

    Circulation   117 ( 15 )   1997 - 2008   2008.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: In allograft rejection, recipient leukocytes and alloantibodies first target donor endothelial cells. Although the leukocyte integrin Mac-1 (alpha(Mbeta2), CD11b/CD18) facilitates cell-cell interactions among leukocytes and interactions between leukocytes and endothelial cells or platelets, its role in allograft survival and vasculopathy is incompletely defined. METHODS AND RESULTS: This study examined parenchymal rejection and graft arterial disease after total allomismatched cardiac transplantation (BALB/c donor heart and B6 recipients) in wild-type (WT) and Mac-1-deficient (Mac-1(-/-)) recipients. Recipient Mac-1 deficiency attenuated parenchymal rejection and significantly prolonged cardiac allograft survival from 8.3+/-1.3 days in WT recipient allografts (n=18) to 13.8+/-2.3 days in Mac-1(-/-) recipient allografts (n=6; P<0.0001). Accumulation of neutrophils and macrophages significantly decreased in Mac-1(-/-) compared with WT recipients. Adoptive transfer of WT but not Mac-1(-/-) macrophages to Mac-1(-/-) recipients exacerbated parenchymal rejection and reduced allograft survival; in contrast, adoptive transfer of WT neutrophils did not affect graft survival. Mac-1(-/-) macrophages expressed significantly lower levels of costimulatory molecules both in vivo and in vitro, and mixed lymphocyte reaction using alloantigen-primed Mac-1(-/-) macrophages resulted in significantly lower antigen-presenting function than for WT macrophages. Tumor necrosis factor-alpha production also fell in cultures with Mac-1(-/-) macrophages. Despite attenuation of acute rejection, recipient Mac-1-deficiency did not prevent late graft arterial disease. CONCLUSIONS: These studies demonstrate critical participation of Mac-1 in alloresponses during cellular allograft rejection. These observations establish a molecular target for modulating recipient responses to prolong graft survival.

    DOI: 10.1161/CIRCULATIONAHA.107.724310

    PubMed

    researchmap

▼display all

Industrial property rights

  • 免疫調節作用を有する単球細胞及びその使用方法

    田中正人, 浅野謙一, 西躰元, 池田直輝

     More details

    Applicant:東京薬科大学

    Application no:特願2018-097457  Date applied:2018.5

    Announcement no:特開2019-201561  Date announced:2019.11

    Patent/Registration no:特許7267562  Date registered:2023.4 

    researchmap

  • 炎症性腸疾患を抑制する抗体および該抗体を含む医薬組成物

    田中正人, 浅野謙一, 高橋直道

     More details

    Applicant:東京薬科大学

    Application no:特願2016-103265  Date applied:2016.5

    Patent/Registration no:特許6947372  Date registered:2021.9 

    researchmap

  • がんの予防および/または治療のための医薬組成物

    田中正人, 浅野謙一, 池田直輝, 四元聡志

     More details

    Applicant:東京薬科大学

    Application no:PCT/JP2022/032534  Date applied:2022.8

    Announcement no:WO/2023/032957  Date announced:2023.3

    researchmap

  • CCL8による免疫細胞の動員が関与する炎症を抑制するための組成物

    田中正人, 浅野謙一

     More details

    Applicant:東京薬科大学

    Application no:特願2021-196208  Date applied:2021.12

    researchmap

  • 多発性骨髄腫の処置のための医薬組成物

    田中 正人, 浅野 謙一

     More details

    Applicant:東京薬科大学

    Application no:特願2021-192959  Date applied:2021.11

    researchmap

  • がん転移抑制のための医薬組成物

    田中正人, 浅野謙一, 四元聡志, 澁谷拓未, 池田直輝

     More details

    Applicant:東京薬科大学

    Application no:特願2021-126801  Date applied:2021.7

    researchmap

▼display all

Research Projects

  • 自己成分変動に伴う自然免疫細胞産生経路の変化とその生理的意義

    Grant number:22H05190  2022.6 - 2027.3

    日本学術振興会  科学研究費助成事業 学術変革領域研究(A)  学術変革領域研究(A)

    浅野 謙一, 池田 直輝

      More details

    Grant amount:\72800000 ( Direct Cost: \56000000 、 Indirect Cost:\16800000 )

    researchmap

  • 制御性単球の分化機構解明と炎症性腸疾患に対する治療応用

    2021.4 - 2024.3

    日本医療研究開発機構  難治性疾患実用化研究事業 

    浅野 謙一, 金井 隆典

      More details

    Authorship:Principal investigator 

    researchmap

  • Regulation of Mucosal Immunity by CD169 Macrophages

    Grant number:26460401  2014.4 - 2017.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    ASANO Kenichi, KIKUCHI Kenta

      More details

    Grant amount:\5070000 ( Direct Cost: \3900000 、 Indirect Cost:\1170000 )

    There are at least 2 subsets of colon macrophages that differ in the expression level of CD169. Selective depletion of CD169 macrophages suppresses DSS-induced colitis in mice. In this study, we revealed that CD169 macrophages produce CCL8 in response to mucosal injury, and that CCL8 recruits inflammatory monocytes to the intestine that furhter aggravate colitis. Administration of anti-CCL8 ameliorates DSS-induced colitis, demonstrating its potential as a novel drug for the treatment of human inflammatory bowel diseases.

    researchmap

  • 腸管センチネル細胞を標的とした炎症性腸疾患治療法の開発

    2011.10 - 2015.3

    科学技術振興機構  戦略的創造研究推進事業(さきがけ) 

    浅野 謙一

      More details

    Authorship:Principal investigator 

    researchmap

  • 好中球様単球の誘導機構と腸炎の病態形成における役割の解明

    Grant number:25K02464  2025.4 - 2029.3

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    浅野 謙一

      More details

    Grant amount:\18720000 ( Direct Cost: \14400000 、 Indirect Cost:\4320000 )

    researchmap

  • Self-referential immune perception

    Grant number:22H05182  2022.6 - 2027.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Transformative Research Areas (A)  Grant-in-Aid for Transformative Research Areas (A)

      More details

    Grant amount:\336180000 ( Direct Cost: \258600000 、 Indirect Cost:\77580000 )

    researchmap

  • Ym1陽性単球由来マクロファージによる肝線維症の進展機序解明

    Grant number:21K06877  2021.4 - 2024.3

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    浅野 謙一, 濱田 理人

      More details

    Grant amount:\4290000 ( Direct Cost: \3300000 、 Indirect Cost:\990000 )

    非アルコール性脂肪肝炎NASHを誘導した肝臓には、血流を介して多量の単球が浸潤する。肝臓に浸潤した単球は、肝臓特異的な環境シグナルによって誘導された転写因子の働きによって、さらにNASH型マクロファージに分化する。NASH型マクロファージは、肝星細胞や線維芽細胞などの間質細胞を活性化することで肝線維化を促進する原因細胞と考えられている。
    そこで、骨髄単球からNASH型マクロファージへの分化を制御する転写因子を同定することを目的として、肝臓マクロファージの遺伝子発現をRNAシークエンス解析し、NASH進展時に発現が亢進する転写因子Egr2を同定した。骨髄系免疫細胞選択的にEgr2を欠損したマウス(Egr2-cKOマウス)を作製し、そのマウスのNASHの病態を解析することで、Egr2の役割を検討した。Egr2-cKOマウス肝臓の、免疫細胞数は野生型と同程度だったが、Egr2-cKOマクロファージにおけるCD11c/CD63/CD88などの表面発現が、野生型に比べ顕著に低下していた。マクロファージの性質の変化をさらに詳細に解析するため、NASH誘導マウスの肝臓マクロファージをCD11c/CD88発現レベルの違いに基づいて分取した。CD11c/CD88二重陽性マクロファージは、Spp1, Trem2, Cd9などNASH型マクロファージのsignature遺伝子群を強発現することが分かった。CD11c/CD88陰性の肝臓マクロファージは、抗炎症性サイトカインIL-10のmRNAレベルが亢進している一方、線維化促進因子PDGFレベルが減弱していることを見出した。これらの研究により、Egr2が、浸潤単球からNASH型マクロファージへの分化に深く関与することが示された。

    researchmap

  • がん免疫におけるマクロファージの役割に関する包括的な理解と診断・治療への応用

    Grant number:20H03459  2020.4 - 2024.3

    日本学術振興会  科学研究費助成事業 基盤研究(B)  基盤研究(B)

    菰原 義弘, 浅野 謙一, 藤原 章雄, 大西 紘二

      More details

    Grant amount:\17550000 ( Direct Cost: \13500000 、 Indirect Cost:\4050000 )

    がん・悪性腫瘍の微小環境には免疫細胞や線維芽細胞、血管内皮細胞など多数の宿主由来細胞が存在する。腫瘍内微小環境におけるマクロファージ(TAM)は腫瘍促進性Protumor/抗炎症性の性質を有しておりPD-L1などの免疫抑制因子を発現している。
    子宮内膜症におけるマクロファージの活性化状態について鉄沈着との関わりを明らかにした(Med Mol Morphol. 54:316-323, 2021.)。今後、子宮内膜症と発がんの関連について研究を進めていく。
    急性期タンパク質であるAGPがマクロファージの活性化(PD-L1発現やIL-6産生)に関わることでがんの発育に関与していることを明らかにした(Cancer Res. 81:4545-4559, 2021)。AGP-CD14シグナルががん治療の標的となり得るかどうかを検討する。
    胃癌のリンパ節におけるマクロファージの活性化状態が、がん免疫サイクルに関わっていることを明らかにした(Front Oncol. 11:636751, 2021)。リンパ節マクロファージの詳細な解析を進めていく。

    researchmap

  • Immune regulation by dead intestinal epithelial cells

    Grant number:17H04052  2017.4 - 2020.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    ASANO Kenichi

      More details

    Grant amount:\17810000 ( Direct Cost: \13700000 、 Indirect Cost:\4110000 )

    We found that tBHP-treated adult mouse small intestinal epithelial cell (aMos7)-derived conditioned medium (CM) enhances CCL8 production by macrophages that were stimulated in vitro with LPS. The CM alone did not induce CCL8 production by macrophages. These findings suggest that a dead cell-derived factor and bacterial components coordinately promote intestinal inflammation. To identify this dead cell-derived molecule, we fractioned CM from tBHP-treated aMos7 cells by HPLC on sizing column monitored with an ultraviolet spectrum detector. A fraction (approximately 1,000 kDa) that showed CCL8 enhancing activity were further separated by HPLC with a reverse phase (C18) column. Mass spectrometry identified Vimentin and hnRNPa1b2-derived peptides that are known as potential endogenous adjuvants. Role of these molecules in the induction of CCL8 by macrophages will be examined by generating Vimentin- or hnRNPa2b1-knock-down aMos7 cells by CRISPR/Cas9 method.

    researchmap

  • The significance of macrophages in several diseases

    Grant number:16H05162  2016.4 - 2020.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    Komohara Yoshihiro

      More details

    Grant amount:\17030000 ( Direct Cost: \13100000 、 Indirect Cost:\3930000 )

    We demonstrated the significance of macrophages in solid tumors, and association between anti-cancer immune responses and macrophage activation.

    researchmap

  • Search of the new biomarkers reflecting lymph node macrophage function and its application to molecular pathology

    Grant number:16K15248  2016.4 - 2019.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Challenging Exploratory Research  Grant-in-Aid for Challenging Exploratory Research

    Takeya Motohiro, FUJIWARA Yukio, KOMOHARA Yoshihiro, ASANO Kenichi

      More details

    Grant amount:\3640000 ( Direct Cost: \2800000 、 Indirect Cost:\840000 )

    In the analysis of the patients of endometrial cancer, pancreatic cancer, bladder cancer and esophagus cancer, positive correlation between CD169-positive rate of lymph node sinus macrophages and overall or cancer-specific survival rate was observed. A concomitant correlation with the density of the intratumoral CD8-positive T lymphocytes was also noted in most cancer cases. We identified that indoleamine 2,3-dioxygenase 1 shows similar expression pattern with CD169 in human macrophages, however, their staining pattern in lymph nodes differed indicating functional association between these molecules may not exist. In colon cancer patients, a possible correlation of blood level of CCL8 and CD169-positive rate of sinus macrophages was indicated, however, the significant difference was not proved.

    researchmap

  • Mechanisms of immunoregulation by dead cell clearance

    Grant number:26110006  2014.7 - 2019.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area)  Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area)

    Tanaka Masato, ASANO Kenichi, OIKAWA Akira

      More details

    Grant amount:\128050000 ( Direct Cost: \98500000 、 Indirect Cost:\29550000 )

    This project aimed to reveal the molecular mechanisms of immunoregulation by dead cell clearance played by macrophages, and obtained following findings; 1. We revealed roles of intestinal CD169-positive macrophages in colitis, and identified the transcriptional factor regulating the function of these macrophages. 2. We revealed the regulatory mechanisms of neutrophil function by macrophages, and the molecular mechanisms of netosis. 3. We identified novel monocyte subset that contributes to repair of injured tissues.

    researchmap

  • CD169陽性マクロファージの分化制御機構の解明

    Grant number:25118729  2013.4 - 2015.3

    日本学術振興会  科学研究費助成事業 新学術領域研究(研究領域提案型)  新学術領域研究(研究領域提案型)

    浅野 謙一

      More details

    Grant amount:\11180000 ( Direct Cost: \8600000 、 Indirect Cost:\2580000 )

    1)CD169陽性マクロファージの分化経路の決定
    平成25年度までの研究で、CD169発現細胞を可視化したfate map mouse(CD169-Cre-YFPマウス)を作製した。このマウスの解析により、CD169発現マクロファージの分布はこれまで想定されていたようなリンパ臓器にとどまらず、皮膚、肝臓、腎臓、脳、消化管など広く全身の臓器に及ぶことが明らかになった。
    組織常在マクロファージはその分化経路により骨髄単球由来と卵黄嚢由来の2集団に大別できる。CD169陽性細胞に占める骨髄単球由来細胞の寄与率を検討するため、CD169-Cre-YFPマウスと蛍光タンパクを発現しないRosa26-YFPマウスを並体融合し、Rosa26-YFPマウスの各組織におけるYFP陽性細胞の頻度をフローサイトメトリーで検討した。3か月後のRosa26-YFPマウスの脳ではYFP陽性細胞をほとんど認めなかったのに対し、腎臓、消化管にはわずかながらYFP陽性細胞が認められた。この結果は、脳のCD169陽性マクロファージがミクログリア同様卵黄嚢由来であるのに対し、後者のCD169陽性マクロファージの少なくとも一部は骨髄単球に由来することを示唆する。
    2)CD169遺伝子の発現制御因子の探索
    リンパ節、大腸、骨髄から、CD169陽性および陰性のマクロファージをセルソーターで分取し、3臓器のCD169陽性細胞集団で共通して強発現する転写因子をマイクロアレイ法で検索した。これまでに候補遺伝子のノックアウトマウスを入手し、各臓器におけるCD169陽性マクロファージの頻度や機能を検討している。

    researchmap

  • The role of CD169 macrophages in anti-tumor immunity induced by dead tumor cells

    Grant number:23390095  2011.4 - 2014.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    TANAKA Masato, ASANO Kenichi, NISHITAI Gen

      More details

    Grant amount:\19760000 ( Direct Cost: \15200000 、 Indirect Cost:\4560000 )

    In this study, we tried to reveal the molecular and cellular mechanisms of activation of anti-tumor immunity by CD169-positive macrophages located in lymph node sinus. We generated CD169-Cre-YFP mice, in which CD169-positive macrophages were specifically labeled with YFP, and examined the character of these cells using the mice. We also identified CD169 macrophages-producing molecules that may be able to activate anti-tumor immunity. We established an experimental model to induce cell death of tumor cells in tumor-bearing mice, found the drastic changes in tumor-associated macrophages after tumor cell death. We also reveal the roles of CD169 macrophages in the immune regulation in non-immune tissues.

    researchmap

  • Clearance of Dead Tumor Cells and Tumor Immunity

    Grant number:21790396  2009 - 2011

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Young Scientists (B)  Grant-in-Aid for Young Scientists (B)

    ASANO Kenichi

      More details

    Grant amount:\4030000 ( Direct Cost: \3100000 、 Indirect Cost:\930000 )

    Tumor cells are considered' altered self' because they accumulate genetic mutations and acquire features that enable them to evade immune surveillance. The generation of tumor-directed cytotoxic T lymphocytes is considered crucial for the induction of anti-tumor immunity. To activate these CD8 T cells, antigen presenting cells(APCs) must initially acquire tumor cell-associated antigens. The major source of tumor antigens is dead tumor cells, but little is known about how APCs in draining lymph nodes acquire and crosspresent these antigens. Here we show that CD169^+macrophages phagocytose dead tumor cells transported via lymphatic flow and subsequently crossprime CD8 T cells. Subcutaneous immunization with irradiated tumor cells protects mice from syngenic tumor. However, tumor antigen-specific CD8 T cell activation and subsequent anti-tumor immunity are severely impaired in mice depleted with CD169^+macrophages. Neither migratory dendritic cells(DCs) nor lymph node-resident conventional DCs are essential for the crosspresentation of tumor antigens. Thus, we have identified lymph node CD169^+macrophages as a novel APC subset dominating early activation of tumor antigen-specific CD8 T cells.

    researchmap

▼display all

Teaching Experience

  • Microbiology

    2024.4 Institution:Yokohama City University

     More details

  • Genetic Engineering

    2013.4 - 2024.3 Institution:Tokyo University of Pharmacy and Life Science

     More details

  • 実験動物学

    2011.4 - 2021.3 Institution:東京薬科大学

     More details